Wyong Rugby Leagues kicks goal to help end melanoma
28 March 2017
Wyong Rugby Leagues kicks goal to help end melanoma Wyong Rugby League Club Group has joined forces with Melanoma Institute Australia to help end melanoma for future generations.
The club has generously donated $60,000 to Melanoma Institute Australia to enable purchase of a new slide stainer which is vital for monitoring individual patient responses to melanoma treatment. The new equipment will help ensure life-saving clinical decisions can be made, including switching therapies should resistance begin to develop.
CEO of Melanoma Institute Australia, Carole Renouf, said the support from Wyong Rugby League Club Group was particularly relevant given the region had been identified as a melanoma hotspot.
“Wyong and the Central Coast are among 28 melanoma hotspots around the state, meaning they have some of the highest rates of melanoma, significantly above the state average,” Ms Renouf said.
“Melanoma is the most common cancer affecting Australians aged 15-39 and kills more 20-39 year olds than any other single cancer. Incidence in the over the 60s is also increasing.
“The support from Wyong Rugby League Club Group means we are equipped with the latest equipment and technology to ensure melanoma patients, many of whom come from the Wyong and Central Coast areas, receive the best possible treatment,” she said.
CEO of Wyong Rugby League Club Group, Michael Coghlan, said with seven venues located on the Central Coast and 50,000 members, it had always been a core focus of the group to support local organisations, sporting groups and the greater community. “We recognise that the Central Coast is a melanoma hotspot and we look forward to growing our partnership and raising awareness with Melanoma Institute Australia,” he said.
The partnership between MIA and Wyong Rugby League Club Group also extends to support of The Longest Melanoma March, a 1200 kilometre trek from Brisbane to Sydney by MIA Community Coordinator and melanoma survivor Jay Allen. Wyong Rugby League Club Group hosted a range of fundraising activities at the Bateau Bay Bowling Club today to welcome Jay as he walked through the Central Coast.
"We sincerely thank Wyong Rugby League Club Group for this generous support,” Ms Renouf said. “It will help us raise awareness about sun-smart behaviour to reduce melanoma risk, and will also assist us in raising vital funds for ongoing research into melanoma prevention and treatment,” she said.
Early lymph node check is saving lives in melanoma patients
We are pleased to announce that A/Prof Anne Cust is the new President of the Australasian Epidemiological Association.
More than $3.5 million in competitive funding grants have been awarded to MIA's researchers.
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.
Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.
A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.
It feels like groundhog day - another reality TV show, another batch of blatantly sunburnt contestants.
Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?
In our latest research update we showcase research in survival estimates, uncover biomarkers, and reveal practice-changing research in surgery and medical oncology.
Senior Clinical Trial Coordinators, like Sarah Lane, support melanoma patients throughout the clinical trial process.
Melanomas are often hard to differentiate from moles. But new technology is helping to improve accuracy of diagnosis.
We are excited to announce that SunSense will proudly be an official supporter of Melanoma Institute Australia. SunSense is an Australian, family owned business.
Five years ago Julie Randall was diagnosed with melanoma and was given months to live. The melanoma had spread throughout her body. The doctors said it was incurable and she’d be lucky if she survived the next nine months. Julie, a patient at Melanoma Institute Australia under Professor Georgina Long was placed on an experimental drug trial. To watch the entire program, visit 9now.com or click here.
Meet our latest Surgical Oncology Fellow, Eva Nagy, to find out more about life as a surgical oncologist, why she came to MIA and what she hopes to achieve.
Melanoma research at ASCO this year focussed on the more precise use of current treatments to ensure optimal treatment for each patient.
MIA recently demonstrated that reflectance confocal microscopy is a useful tool in the clinic to diagnose suspicious-looking lesions in the mouth.
New research is likely to change the way melanoma is managed in many patients by reducing the need for major surgery and its associated morbidity and cost.
Researchers from MIA will present their latest research findings to the world’s largest oncology conference in early June.